Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Appointed director Quarterly results Asset disposition Acq. announced Director departure
|
MEI Pharma, Inc. (MEIP)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/13/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
09/26/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
08/08/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
07/17/2023 |
SC 13D/A
| Anson Funds Management LP reports a 9.9% stake in MEI Pharma, Inc. |
03/09/2023 |
SC 13D/A
| Growth Equity Opportunities V, LLC has filed a Schedule 13D for MEI Pharma, Inc. |
12/30/2019 |
SC 13D/A
| Growth Equity Opportunities V, LLC reports a 9.8% stake in MEI Pharma, Inc. |
06/03/2016 |
SC 13D/A
| VIVO VENTURES VII, LLC reports a 3.6% stake in MEI Pharma, Inc. |
04/22/2016 |
SC 13D/A
| VIVO VENTURES VII, LLC reports a 5% stake in MEI Pharma, Inc. |
04/15/2016 |
SC 13D/A
| VIVO VENTURES VII, LLC reports a 6% stake in MEI Pharma, Inc. |
04/07/2016 |
SC 13D/A
| VIVO VENTURES VII, LLC reports a 7.2% stake in MEI Pharma, Inc. |
03/10/2016 |
SC 13D/A
| VIVO VENTURES VII, LLC reports a 8.3% stake in MEI Pharma, Inc. |
11/06/2013 |
SC 13D/A
| New Leaf Ventures II, L.P. reports a 17.6% stake in MEI Pharma, Inc. |
03/05/2013 |
SC 13D/A
| BAKER BROS ADVISORS LLC reports a 7.6% stake in MEI Pharma, Inc |
02/27/2013 |
SC 13D/A
| BAKER BROS ADVISORS LLC reports a 9.1% stake in MEI Pharma, Inc |
10/19/2012 |
SC 13D/A
| MARSHALL EDWARDS INC reports a 69.9% stake in MEI Pharma, Inc. |
05/25/2012 |
SC 13D/A
| MARSHALL EDWARDS INC reports a 72.8% stake in Marshall Edwards, Inc. |
01/05/2012 |
SC 13D/A
| NOVOGEN LTD reports a 58.1% stake in Marshall Edwards, Inc. |
10/05/2011 |
SC 13D/A
| NOVOGEN LTD reports a 68.5% stake in Marshall Edwards, Inc. |
05/11/2011 |
SC 13D/A
| NOVOGEN LTD has filed a Schedule 13D for Marshall Edwards, Inc. |
03/11/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
12/30/2010 |
SC 13D/A
| NOVOGEN LTD has filed a Schedule 13D for Marshall Edwards, Inc. |
|
|